BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Foley LS, Kulungowski AM. Vascular Anomalies in Pediatrics. Advances in Pediatrics 2015;62:227-55. [DOI: 10.1016/j.yapd.2015.04.009] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Cheng J, Liu B, Farjat AE, Routh J. National Characteristics of Lymphatic Malformations in Children: Inpatient Estimates and Trends in the United States, 2000 to 2009. J Pediatr Hematol Oncol 2018;40:221-3. [PMID: 29293192 DOI: 10.1097/MPH.0000000000001078] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Leszczynska M, Jodeh DS, Reed D, Lynskey EM, Bittles MA, Mayer JL, Rottgers SA. Alveolar soft‐part sarcoma: Case demonstrating principles for uncommon vascular lesions. Pediatrics International 2019;61:978-81. [DOI: 10.1111/ped.13920] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
3 Bonilla-Velez J, Whitlock KB, Ganti S, Theeuwen HA, Manning SC, Bly RA, Dahl JP, Perkins JA. Active Observation as an Alternative to Invasive Treatments for Pediatric Head and Neck Lymphatic Malformations. Laryngoscope 2021;131:1392-7. [PMID: 33107991 DOI: 10.1002/lary.29180] [Reference Citation Analysis]
4 Glaser K, Dickie P, Neilson D, Osborn A, Dickie BH. Linkage of Metabolic Defects to Activated PIK3CA Alleles in Endothelial Cells Derived from Lymphatic Malformation. Lymphat Res Biol 2018;16:43-55. [PMID: 29346025 DOI: 10.1089/lrb.2017.0033] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
5 Samadi K, Salazar GM. Role of imaging in the diagnosis of vascular malformations vascular malformations. Cardiovasc Diagn Ther 2019;9:S143-51. [PMID: 31559160 DOI: 10.21037/cdt.2018.08.06] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
6 Szhafir I, Teplisky D, Lambert G, Affranchino N, Weller S, Imizcoz FL, Corbetta JP, Sierre S. The Impact of Adjuvant Sirolimus Therapy in the Surgical Management of Scrotal Slow-Flow Vascular Malformations. Urology 2021;147:270-4. [PMID: 32920033 DOI: 10.1016/j.urology.2020.08.051] [Reference Citation Analysis]
7 Scorletti F, Hammill A, Patel M, Ricci K, Dasgupta R. Malignant tumors misdiagnosed as benign vascular anomalies. Pediatr Blood Cancer 2018;65:e27051. [DOI: 10.1002/pbc.27051] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Wu HW, Wang X, Zheng JW, Zhao HG, Ge J, Zhang L, Wang YA, Su LX, Fan XD. Treatment of deep-seated facial microcystic lymphatic malformations with intralesional injection of pingyangmycin. Medicine (Baltimore) 2016;95:e4790. [PMID: 27631231 DOI: 10.1097/MD.0000000000004790] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
9 Slaughter KA, Chen T, Williams E. Vascular Lesions. Facial Plastic Surgery Clinics of North America 2016;24:559-71. [DOI: 10.1016/j.fsc.2016.06.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
10 Ozeki M, Nozawa A, Yasue S, Endo S, Asada R, Hashimoto H, Fukao T. The impact of sirolimus therapy on lesion size, clinical symptoms, and quality of life of patients with lymphatic anomalies. Orphanet J Rare Dis 2019;14:141. [PMID: 31196128 DOI: 10.1186/s13023-019-1118-1] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 8.3] [Reference Citation Analysis]
11 Pang C, Gibson M, Nisbet R, Evans N, Khalifa M, Papadopoulou A, Tsui J, Hamilton G, Brookes J, Lim CS. Quality of life and mental health of patients with vascular malformations in a single specialist center in the United Kingdom. J Vasc Surg Venous Lymphat Disord 2021:S2213-333X(21)00199-2. [PMID: 33872818 DOI: 10.1016/j.jvsv.2021.03.019] [Reference Citation Analysis]
12 Cheng J, Liu B, Farjat AE, Routh J. The Public Health Burden of Lymphatic Malformations in Children: National Estimates in the United States, 2000-2009. Lymphat Res Biol 2017;15:241-5. [PMID: 28759318 DOI: 10.1089/lrb.2017.0009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
13 Ozeki M, Asada R, Saito AM, Hashimoto H, Fujimura T, Kuroda T, Ueno S, Watanabe S, Nosaka S, Miyasaka M, Umezawa A, Matsuoka K, Maekawa T, Yamada Y, Fujino A, Hirakawa S, Furukawa T, Tajiri T, Kinoshita Y, Souzaki R, Fukao T. Efficacy and safety of sirolimus treatment for intractable lymphatic anomalies: A study protocol for an open-label, single-arm, multicenter, prospective study (SILA). Regen Ther 2019;10:84-91. [PMID: 30705924 DOI: 10.1016/j.reth.2018.12.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
14 Ricci KW. Advances in the Medical Management of Vascular Anomalies. Semin Intervent Radiol 2017;34:239-49. [PMID: 28955113 DOI: 10.1055/s-0037-1604297] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.6] [Reference Citation Analysis]
15 Wang H, Guo X, Duan Y, Zheng B, Gao Y. Sirolimus as initial therapy for kaposiform hemangioendothelioma and tufted angioma. Pediatr Dermatol 2018;35:635-8. [PMID: 29999213 DOI: 10.1111/pde.13600] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]